Taylor Ashley counsels clients on mergers, acquisitions and other strategic transactions, as well as SEC compliance matters. He represents publicly traded, privately held and private equity backed businesses in various industries including senior living, manufacturing, healthcare and consumer. Since 2015, Taylor has served as first chair associate on numerous M&A transactions collectively valued at more than $5 billion, including a complex, multibillion dollar sale of a publicly traded manufacturing company.
Prior to joining Bass, Berry & Sims, Taylor was an associate at the Dallas office of Jones Day where he advised clients in matters related to public and private mergers and acquisitions and capital markets.
American Health Lawyers Association (AHLA)
Health Enterprise Partners Invests in AxiaMed
Represented CRH Healthcare in its acquisition of SmartCare Urgent Care
We represented United Derm Partners, a portfolio company of Frazier Healthcare Partners, in its acquisition of two skincare and dermatology practices.
Represented Brookdale Senior Living Inc. (NYSE: BKD) in its sale of 41 communities
Represented CHS in its $2.2 billion secured notes offering
Represented CLARCOR Inc. (NYSE: CLC) in its acquisition by Parker Hannifin Corporation (NYSE: PH) for approximately $4.3 billion in cash
Represented LoJac Holdings Corp. in its sale of three divisions to Vulcan Materials Co.
Represented Advanced Dermatology & Cosmetic Surgery in its acquisition of 15 skin and dermatology practices in 2016
Represented Advanced Dermatology & Cosmetic Surgery in its acquisition of 16 skin and dermatology practices in six states across the country
Represented United Natural Foods Inc. (Nasdaq: UNFI) in its acquisition of Haddon House Food Products Inc; Nor-Cal Produce, Inc.; and Global/Organic Specialty Source, Inc.
Harvard Law School — “Best Representation” in the 56th Annual Williston Negotiation Competition
Harvard Law School — Dean’s Scholar Prize in Law and the International Economy